Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECLAIM: Metformin and Colchicine in Post-COVID Condition
NCT07280572Phase 3Enrolling by invitation
- Start
- Feb 2025
- Primary completion
- Dec 2027
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of metformin, colchicine in post-COVID condition (PCC). Started Feb 2025; status: enrolling by invitation.
02
Drugs
metformincolchicine
03
Conditions
post-COVID condition (PCC)
Beyond the preview
Go deeper on NCT07280572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07280572.